Related Experiment Video
Updated: Aug 4, 2026

08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
What to do with HLA-DO?
M van Ham1, M van Lith, A Griekspoor
1Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam. vanham@nki.nl
Immunogenetics
|September 2, 2000
Summary
Human Leukocyte Antigen-DM (HLA-DM) is a chaperone protein crucial for antigen presentation by MHC class II molecules. The newly discovered HLA-DO molecule interacts with HLA-DM, influencing its function, particularly in B cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Antigenic peptide binding to MHC class II molecules is a complex process.
- HLA-DM acts as a specialized lysosomal chaperone, essential for this process.
- HLA-DM shares structural homology with MHC class I and II molecules and is expressed in antigen-presenting cells.
Purpose of the Study:
- To review the effects of the HLA-DO molecule on HLA-DM-mediated antigen presentation.
- To discuss the physiological relevance of HLA-DO's B cell-specific expression and function.
Main Methods:
- Review of existing literature on HLA-DM and HLA-DO function.
- Analysis of structural and genetic homologies between HLA-DM, HLA-DO, and MHC molecules.
- Evaluation of the impact of HLA-DO on HLA-DM activity in antigen presentation.
Main Results:
- HLA-DM catalyzes the dissociation of unstable peptides from MHC class II, promoting stable antigenic peptide presentation.
- HLA-DO associates with HLA-DM, significantly altering its function.
- HLA-DO is primarily expressed in B cells, suggesting a specialized role in B cell immunity.
Conclusions:
- HLA-DO plays a unique role in modulating HLA-DM activity during antigen presentation by MHC class II molecules.
- The B cell-specific expression of HLA-DO indicates a critical function in B cell-mediated immune responses.
- Further research is needed to fully elucidate the physiological implications of HLA-DO's interaction with HLA-DM.
More Related Videos
Related Concept Videos
Cell-mediated Immune Responses
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

